Citation: Rd. Hull et Gf. Pineo, PROPHYLAXIS OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - CURRENT RECOMMENDATIONS, Clinical and applied thrombosis/hemostasis, 4(2), 1998, pp. 96-104
Citation: Rd. Hull et Gf. Pineo, LOW-MOLECULAR-WEIGHT HEPARIN IN TREATMENT OF VENOUS THROMBOEMBOLISM -AN EMERGING THEME, International angiology, 17(3), 1998, pp. 131-134
Citation: Rd. Hull et Gf. Pineo, PROPHYLAXIS OF DEEP VENOUS THROMBOSIS AND PULMONARY-EMBOLISM - CURRENT RECOMMENDATIONS, The Medical clinics of North America, 82(3), 1998, pp. 477
Citation: Gf. Pineo et Rd. Hull, UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN - COMPARISONS AND CURRENT RECOMMENDATIONS, The Medical clinics of North America, 82(3), 1998, pp. 587
Citation: Rd. Hull et al., HIRUDIN VERSUS HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN - AND THE WINNER IS, The Journal of laboratory and clinical medicine, 132(3), 1998, pp. 171-174
Citation: Ge. Raskob et al., THE IMPORTANCE AT INITIAL HEPARIN TREATMENT ON LONG-TERM CLINICAL OUTCOMES - IN REPLY, Archives of internal medicine, 158(11), 1998, pp. 1271-1272
Authors:
RASKOB GE
HULL RD
PINEO GF
VALENTINE KA
BRANT RF
Citation: Ge. Raskob et al., RELATION BETWEEN TIME TO ACHIEVE THE LOWER LIMIT OF APTT RANGE AND RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH VENOUS THROMBOSIS, Journal of the American College of Cardiology, 29(2), 1997, pp. 63107-63107
Authors:
PINEO GF
HULL RD
ROSENBLOOM D
RASKOB GE
GAFNI A
Citation: Gf. Pineo et al., A COST-EFFECTIVENESS ANALYSIS OF LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH CONTINUOUS INTRAVENOUS HEPARIN IN THE TREATMENT OF PROXIMAL VEIN-THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 1182-1182
Authors:
VALENTINE KA
HULL RD
RASKOB GE
PINEO GF
BRANT RF
Citation: Ka. Valentine et al., THE RELATIONSHIP BETWEEN INITIAL HEPARIN-THERAPY AND RECURRENT VENOUSTHROMBOEMBOLISM IN PATIENTS WITH VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 1185-1185
Authors:
PINEO GF
HULL RD
RASKOB GE
BRANT RF
GREEN D
Citation: Gf. Pineo et al., DECREASED MORTALITY IN CANCER-PATIENTS TREATED FOR PROXIMAL DEEP-VEINTHROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARIN AS COMPARED WITH UNFRACTIONATED HEPARIN, Thrombosis and haemostasis, 1997, pp. 1566-1566
Authors:
HULL RD
PINEO GF
VALENTINE KA
STAGG V
BRANT RF
Citation: Rd. Hull et al., PREOPERATIVE ENOXAPARIN IS MORE EFFECTIVE THAN POSTOPERATIVE ENOXAPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS (DVT) IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT (THR) - A POOLED ANALYSIS, Thrombosis and haemostasis, 1997, pp. 1578-1578
Authors:
HULL RD
RASKOB GE
PINEO GF
FELDSTEIN W
ROSENBLOOM D
GAFNI A
GREEN D
FEINGLASS J
TROWBRIDGE A
ELLIOTT CG
LERNER R
BRANT RF
Citation: Rd. Hull et al., SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) VERSUS WARFARIN SODIUM (WS) FOR PROPHYLAXIS OF DEEP-VEIN THROMBOSIS (DVT) AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENT (THR TKR) - AN ECONOMIC-PERSPECTIVE/, Thrombosis and haemostasis, 1997, pp. 1579-1579
Citation: Rd. Hull et al., A RANDOMIZED TRIAL COMPARING THE EFFECTS OF LONG-TERM LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) WITH LMWH PLUS WARFARIN ON THE QUALITY-OF-LIFE AND SAFETY IN THE HOME TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS (DVT) - THE HOME-LITE STUDY, Thrombosis and haemostasis, 1997, pp. 1991-1991
Authors:
VALENTINE KA
HULL RD
PINEO GF
FELDSTEIN W
RASKOB GE
Citation: Ka. Valentine et al., COST-EFFECTIVENESS OF DIAGNOSIS AND MANAGEMENT OF DEEP-VEIN THROMBOSIS (DVT) IN SYMPTOMATIC PATIENTS COMPARING LOW-MOLECULAR-WEIGHT HEPARIN(LMWH) AND INTRAVENOUS HEPARIN (IVH) FOR TREATMENT, Thrombosis and haemostasis, 1997, pp. 1997-1997
Citation: Ka. Valentine et al., FREQUENCY OF PULMONARY-EMBOLISM (PE) IN PATIENTS PRESENTING WITH PROXIMAL DEEP-VEIN THROMBOSIS (DVT), Thrombosis and haemostasis, 1997, pp. 2909-2909
Authors:
PINKERTON LE
MASSOUDI M
BERNSTEIN D
BIAGINI R
HULL RD
RUDER A
BROWN M
BOENIGER M
WARD E
Citation: Le. Pinkerton et al., OCCUPATIONAL ASTHMA AND RHINITIS AMONG EGG-PROCESSING WORKERS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 2029-2029
Citation: Gf. Pineo et Rd. Hull, LOW-MOLECULAR-WEIGHT HEPARIN - PROPHYLAXIS AND TREATMENT OF VENOUS THROMBOEMBOLISM, Annual review of medicine, 48, 1997, pp. 79-91